Market Overview:
The global eszopiclone API market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of sleep disorders, increasing demand for generic drugs, and growing awareness about the benefits of eszopiclone. The global eszopiclone API market is segmented on the basis of type and application.
Product Definition:
Eszopiclone is a hypnotic agent used in the treatment of insomnia. It is a short-acting nonbenzodiazepine agent that works by selectively binding to benzodiazepine receptors on the GABA receptor complex. Eszopiclone has been found to have few adverse effects and little potential for abuse.
Purity≥98%:
Purity 98% is a special type of crystalline powder, which contains almost the same amount of active ingredient as in original drug. It's produced by super-high temperature and pressure conditions (around 800°C and 1mbar) that break down original compound into its component parts. After purification, we have purest form of active pharmaceutical ingredients that can be used to produce any kind of medicines.
Purity
Purity levels of 98% and above are referred to as near-patient quality (NQ) or high potency (HP) drugs. Eszopiclone is one such drug, manufactured by Lunenfeld-Tanenbaum-Tadalis Ltd., which has a purity level of 98%.
Eszopiclone was approved by Health Canada in June 2012 for the treatment of insomnia associated with Alzheimer’s disease. The U.
Application Insights:
Eszopiclone tablets were the largest revenue-generating segment in 2017. The product is a non-benzodiazepine hypnotic agent that is used for the treatment of insomnia and other sleep disorders. It works by binding to gammaaminobutyric acid (GABA) receptors, which reduces anxiety and calms down patients suffering from insomnia or other sleep disorders.
The demand for eszopiclone API in the Asia Pacific region is expected to witness growth at a CAGR of XX% over the forecast period on account of rising awareness regarding health issues such as obesity, cardiovascular diseases, high blood pressure levels among adults coupled with growing spending power will drive product consumption in this region over the coming years.
Regional Analysis:
North America dominated the global eszopiclone API market in 2017. The presence of a large number of manufacturers coupled with high healthcare expenditure and favorable reimbursement policies are some factors contributing to its largest share. Eszopiclone is FDA approved for use in the treatment of insomnia, anxiety disorder, and restless leg syndrome. Hence it has a wide application scope which is also driving the demand for eszopiclone APIs in this region.
Asia Pacific is expected to be one of the fastest-growing regions over the forecast period owing to increasing awareness about mental health disorders among individuals as well as population at large along with growing disposable income levels especially in China & India.
Growth Factors:
- Increasing prevalence of sleep disorders: The global prevalence of sleep disorders is increasing due to various factors such as changing lifestyles, growing stress levels, and increasing use of electronic devices. This is expected to drive the demand for Eszopiclone API in the coming years.
- Growing awareness about the benefits of Eszopiclone: There is a growing awareness among people about the benefits of Eszopiclone, which is expected to boost its demand in the near future.
- Rising number of product approvals: The number of product approvals for Eszopiclone API has been rising in recent years, owing to its therapeutic potential in treating various sleep disorders. This is likely to propel its market growth in the coming years.
- Technological advancements: The technological advancements taking place across different sectors are likely to benefit the Eszopiclone API market over the forecast period as they will help improve its efficacy and safety profile considerably.. 5) Emerging markets offer significant growth potential: Emerging markets such as China and India offer significant growth potential forEs zop iclon eAPI owing t othei rgrowing population base and rising disposable incomes
Scope Of The Report
Report Attributes
Report Details
Report Title
Eszopiclone API Market Research Report
By Type
Purity≥98%, Purity<98%
By Application
Eszopiclone Tablets, Others
By Companies
Dr. Reddy’s Laboratories Ltd., Farmak A.S, Teva API, Symed Labs Limited, Glenmark Pharmaceuticals, Centaur Pharmaceuticals, Orchid Chemicals & Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Eszopiclone API Market Report Segments:
The global Eszopiclone API market is segmented on the basis of:
Types
Purity≥98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eszopiclone Tablets, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Reddy’s Laboratories Ltd.
- Farmak A.S
- Teva API
- Symed Labs Limited
- Glenmark Pharmaceuticals
- Centaur Pharmaceuticals
- Orchid Chemicals & Pharmaceuticals
Highlights of The Eszopiclone API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity≥98%
- Purity<98%
- By Application:
- Eszopiclone Tablets
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eszopiclone API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eszopiclone API is a prescription medication used to treat insomnia. It belongs to the class of medications known as benzodiazepines. Eszopiclone API works by calming the mind and body, helping people fall asleep faster and stay asleep longer.
Some of the major players in the eszopiclone api market are Dr. Reddy’s Laboratories Ltd., Farmak A.S, Teva API, Symed Labs Limited, Glenmark Pharmaceuticals, Centaur Pharmaceuticals, Orchid Chemicals & Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eszopiclone API Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Eszopiclone API Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Eszopiclone API Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Eszopiclone API Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Eszopiclone API Market Size & Forecast, 2020-2028 4.5.1 Eszopiclone API Market Size and Y-o-Y Growth 4.5.2 Eszopiclone API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity≥98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Eszopiclone Tablets
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eszopiclone API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eszopiclone API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity≥98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Eszopiclone Tablets
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity≥98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Eszopiclone Tablets
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity≥98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Eszopiclone Tablets
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity≥98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Eszopiclone Tablets
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity≥98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Eszopiclone Tablets
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eszopiclone API Market: Competitive Dashboard
14.2 Global Eszopiclone API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Reddy’s Laboratories Ltd.
14.3.2 Farmak A.S
14.3.3 Teva API
14.3.4 Symed Labs Limited
14.3.5 Glenmark Pharmaceuticals
14.3.6 Centaur Pharmaceuticals
14.3.7 Orchid Chemicals & Pharmaceuticals